Hsieh, P., Ho, H., Hsieh, S., Kuo, Y., Tseng, H., Kao, H., & Wang, J. (2020). Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice. BMJ Open Diabetes Res Care.
Chicago ZitierstilHsieh, Pei-Shan, Hsieh-Hsun Ho, Shih-Hung Hsieh, Yi-Wei Kuo, Hsiu-Ying Tseng, Hui-Fang Kao, und Jiu-Yao Wang. "Lactobacillus Salivarius AP-32 and Lactobacillus Reuteri GL-104 Decrease Glycemic Levels and Attenuate Diabetes-mediated Liver and Kidney Injury in Db/db Mice." BMJ Open Diabetes Res Care 2020.
MLA ZitierstilHsieh, Pei-Shan, et al. "Lactobacillus Salivarius AP-32 and Lactobacillus Reuteri GL-104 Decrease Glycemic Levels and Attenuate Diabetes-mediated Liver and Kidney Injury in Db/db Mice." BMJ Open Diabetes Res Care 2020.